Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Baggiolini, 1989, Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils, J Clin Invest, 84, 1045, 10.1172/JCI114265
Sanmamed, 2014, Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins, Clin Cancer Res, 20, 5697, 10.1158/1078-0432.CCR-13-3203
Infanger, 2013, Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche, Cancer Res, 73, 7079, 10.1158/0008-5472.CAN-13-1355
Kotyza, 2012, Interleukin-8 (CXCL8) in tumor associated non-vascular extracellular fluids: its diagnostic and prognostic values. A review, Int J Biol Markers, 27, 169, 10.5301/JBM.2012.9261
Singh, 2013, Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells, Breast Cancer Res, 15, 210, 10.1186/bcr3436
Walz, 1987, Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes, Biochem Biophys Res Commun, 149, 755, 10.1016/0006-291X(87)90432-3
Waugh, 2008, The interleukin-8 pathway in cancer, Clin Cancer Res, 14, 6735, 10.1158/1078-0432.CCR-07-4843
Xie, 2001, Interleukin-8 and human cancer biology, Cytokine Growth Factor Rev, 12, 375, 10.1016/S1359-6101(01)00016-8
Yuan, 2005, The role of interleukin-8 in cancer cells and microenvironment interaction, Front Biosci, 10, 853, 10.2741/1579
Alfaro, 2011, Carcinoma-derived interleukin-8 disorients dendritic cell migration without impairing T-cell stimulation, PLoS One, 6, e17922, 10.1371/journal.pone.0017922
Fan, 2007, Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8, J Biol Chem, 282, 11658, 10.1074/jbc.M607705200
Gordon, 2010, Alternative activation of macrophages: mechanism and functions, Immunity, 32, 593, 10.1016/j.immuni.2010.05.007
Noy, 2014, Tumor-associated macrophages: from mechanisms to therapy, Immunity, 41, 49, 10.1016/j.immuni.2014.06.010
Ferrara, 2010, Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis, Curr Opin Hematol, 17, 219
Mantovani, 2011, Cancer-promoting tumor-associated macrophages: new vistas and open questions, Eur J Immunol, 41, 2522, 10.1002/eji.201141894
Gabrilovich, 2012, Coordinated regulation of myeloid cells by tumours, Nat Rev Immunol, 12, 253, 10.1038/nri3175
Arina, 2015, Myeloid-derived suppressor cell impact on endogenous and adoptively transferred T cells, Curr Opin Immunol, 33, 120, 10.1016/j.coi.2015.02.006
Berraondo, 2007, Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system, Cancer Res, 67, 8847, 10.1158/0008-5472.CAN-07-0321
Ugel, 2009, Therapeutic targeting of myeloid-derived suppressor cells, Curr Opin Pharmacol, 9, 470, 10.1016/j.coph.2009.06.014
Condamine, 2015, Regulation of tumor metastasis by myeloid-derived suppressor cells, Annu Rev Med, 66, 97, 10.1146/annurev-med-051013-052304
Kitano, 2014, Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes, Cancer Immunol Res, 2, 812, 10.1158/2326-6066.CIR-14-0013
Kotsakis, 2012, Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples, J Immunol Methods, 381, 14, 10.1016/j.jim.2012.04.004
Nagaraj, 2010, Myeloid-derived suppressor cells in human cancer, Cancer J, 16, 348, 10.1097/PPO.0b013e3181eb3358
Pak, 1995, Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor, Clin Cancer Res, 1, 95
Poschke, 2012, On the armament and appearances of human myeloid-derived suppressor cells, Clin Immunol, 144, 250, 10.1016/j.clim.2012.06.003
Kalathil, 2013, Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality, Cancer Res, 73, 2435, 10.1158/0008-5472.CAN-12-3381
Pico de Coana, 2014, Myeloid-derived suppressor cells and their role in CTLA-4 blockade therapy, Cancer Immunol Immunother, 63, 977, 10.1007/s00262-014-1570-7
Weide, 2014, Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells, Clin Cancer Res, 20, 1601, 10.1158/1078-0432.CCR-13-2508
Feijoo, 2005, Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8, Int J Cancer, 116, 275, 10.1002/ijc.21046
Brinkmann, 2004, Neutrophil extracellular traps kill bacteria, Science, 303, 1532, 10.1126/science.1092385
Brinkmann, 2012, Neutrophil extracellular traps: is immunity the second function of chromatin?, J Cell Biol, 198, 773, 10.1083/jcb.201203170
Clark, 2007, Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood, Nat Med, 13, 463, 10.1038/nm1565
Pilsczek, 2010, A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus, J Immunol, 185, 7413, 10.4049/jimmunol.1000675
Urban, 2009, Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans, PLoS Pathog, 5, e1000639, 10.1371/journal.ppat.1000639
Sangaletti, 2012, Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity, Blood, 120, 3007, 10.1182/blood-2012-03-416156
Cools-Lartigue, 2013, Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis, J Clin Invest, 67484
Bizzarri, 2006, ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets, Pharmacol Ther, 112, 139, 10.1016/j.pharmthera.2006.04.002
Citro, 2012, CXCR1/2 inhibition enhances pancreatic islet survival after transplantation, J Clin Invest, 122, 3647, 10.1172/JCI63089
Bronte, 2003, IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice, J Immunol, 170, 270, 10.4049/jimmunol.170.1.270
Ochoa, 2012, Liver gene transfer of interkeukin-15 constructs that become part of circulating high density lipoproteins for immunotherapy, PLoS One, 7, e52370, 10.1371/journal.pone.0052370
Ochoa, 2013, Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein, Cancer Res, 73, 139, 10.1158/0008-5472.CAN-12-2660
Citro, 2015, CXCR1/2 inhibition blocks and reverses type 1 diabetes in mice, Diabetes, 64, 1329, 10.2337/db14-0443
Gallina, 2006, Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells, J Clin Invest, 116, 2777, 10.1172/JCI28828
Serafini, 2004, Derangement of immune responses by myeloid suppressor cells, Cancer Immunol Immunother, 53, 64, 10.1007/s00262-003-0443-2
Di Mitri, 2014, Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer, Nature, 515, 134, 10.1038/nature13638
Lesokhin, 2012, Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment, Cancer Res, 72, 876, 10.1158/0008-5472.CAN-11-1792
Gentles, 2015, The prognostic landscape of genes and infiltrating immune cells across human cancers, Nat Med, 21, 938, 10.1038/nm.3909
Yalavarthi, 2015, Antiphospholipid antibodies promote the release of neutrophil extracellular traps: a new mechanism of thrombosis in the antiphospholipid syndrome, Arthritis Rheumatol, 67, 2990, 10.1002/art.39247
Tanaka, 2014, In vivo characterization of neutrophil extracellular traps in various organs of a murine sepsis model, PLoS One, 9, e111888, 10.1371/journal.pone.0111888
Highfill, 2014, Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy, Sci Transl Med, 6, 237ra67, 10.1126/scitranslmed.3007974